kubapharms[.]com
“Home - Buy research chemicals online - Kubapharms Meds”
kubapharms.com — Erro no servidor (HTTP 502). Representação da marca: Compound; Tipo de golpe: E Commerce Scam. Resumo das evidências: VirusTotal 2/94 (Bfore.Ai PreCrime, Fortinet); PhishDestroy score 56/100. Registrador: NiceNIC.
A análise detalhada do PhishDestroy AI permanece em inglês para preservar o registro forense original.
kubapharms.com is an active domain registered on April 13, 2025, currently under investigation for generic phishing threats. There is no specific brand or drainer kit clearly identified at this time, but its association with phishing indicates an intent to deceive visitors into revealing sensitive information.
Technical analysis shows that kubapharms.com has a VirusTotal detection score of 2 out of 95, meaning it is not yet flagged by most antivirus engines. The domain was registered through NICENIC INTERNATIONAL GROUP CO., LIMITED and resolves to the IP address 92.113.23.191. It uses a Let's Encrypt SSL certificate, which indicates encrypted traffic but does not guarantee legitimacy. The domain is blocked by PhishDestroy and appears on 1 known security blocklist. Google Safe Browsing (GSB) status is not specified.
Currently, kubapharms.com remains active and under investigation. Users are advised to exercise caution and avoid submitting any personal information or credentials on this site. Despite the lack of detections on VirusTotal, its presence on blocklists and PhishDestroy's intervention highlight a potential risk. Security teams should continue monitoring this domain and block it where possible to mitigate exposure to phishing threats.
Inteligência de segurança de rede Registrar context
Pipeline de resposta a ameaças
Status da lista de bloqueios pública
Captura armazenada
Inteligência de Domínios
Detalhes técnicosDNS, SANs do SSL, carimbos de data e hora
ICANN OVERSIGHT
Credenciamento e contexto RAA
Credenciamento e contexto RAA
Registrar accreditation and DNS abuse obligations
For this gTLD, the registrar above operates under an ICANN accreditation agreement. The links below provide the official fee schedule and current DNS abuse compliance guidance.
Accreditation is a contract, not a safety certification.
RAA §3.18 establishes abuse-contact and handling requirements. This report can document stored outbound notices and later technical observations; it does not by itself establish receipt, investigation, remediation, or contractual non-compliance.
Latest Classified Outcome 2026-08-13 03:07:00 UTC
Tecnologias · 9 identified
Open-source CMS powering over 40% of websites worldwide.
Open-source relational database management system.
Server-side scripting language designed for web development.
Plugin to detect and restore deprecated jQuery features.
Fast, small JavaScript library simplifying HTML manipulation, event handling, and Ajax.
Third major version of HTTP protocol, built on QUIC for faster, more reliable connections.
Análise do VirusTotal
Análise de desempenho do site
Google PageSpeed Insights — mobile performance audit of kubapharms.com · checked Mar 27, 2026
Evidências e relatórios externos
PD-20260327-52D462 Recipient: abuse@nicenic.net, abuse@verisign-grs.com, compliance@icann.org Você foi afetado por este site?
Se você inseriu credenciais de conta, informações pessoais ou de pagamento, ou baixou um arquivo deste domínio, tome medidas imediatas. Abaixo estão os recursos para ajudá-lo a relatar o incidente e se proteger.
Notifique as autoridades locais
Selecione seu país para obter contactos oficiais do cibercrime ou crie um rascunho de reclamação →.
Verificar qualquer domínio
Análise de ameaças usando lista de bloqueio armazenada, WHOIS, DNS e evidências de verificação pública
Digitalize agoraDenunciar phishing
Envie domínios suspeitos para nosso banco de dados de ameaças — proteja a comunidade
DenunciarFeed de ameaças em tempo real
Relatórios recentes de phishing e alterações de disponibilidade observadas
MonitorarMantenha-se informado, mantenha-se seguro
Monitore ameaças em tempo real ou conteste esta listagem caso acredite que se trate de um falso positivo